StockNews.com began coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a research note published on Sunday morning. The firm issued a sell rating on the stock.
Separately, HC Wainwright upped their price objective on SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a research note on Thursday, December 12th.
View Our Latest Research Report on SNES
SenesTech Trading Up 3.7 %
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Further Reading
- Five stocks we like better than SenesTech
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- How to Invest in Biotech Stocks
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- What is Short Interest? How to Use It
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.